| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $60.6M | +71.7% |
| SG&A Expense | $5.6M | +37.4% |
| Operating Income | -$66.2M | -68.1% |
| Interest Expense | $5.3M | +152.9% |
| Pre-tax Income | -$63.8M | -58.0% |
| Net Income | -$63.8M | -58.0% |
| EPS (Basic) | -$2.69 | -1.9% |
| EPS (Diluted) | -$2.69 | -1.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.7M | +24.8% |
| Short-term Investments | $149.9M | +4.1% |
| Current Assets | $190.6M | +8.8% |
| Total Assets | $191.2M | +8.8% |
| Current Liabilities | $14.2M | +106.2% |
| Long-term Debt | $37.6M | +5.1% |
| Total Liabilities | $51.5M | +22.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.8M | -49.4% |
| Capital Expenditures | $98K | -38.5% |
| Investing Cash Flow | -$5.0M | +96.5% |
| Financing Cash Flow | $64.9M | -46.1% |
| Free Cash Flow | -$53.9M | -49.1% |
| Stockholders' Equity |
| $139.8M |
| +4.5% |